Skip to main content

Boric acid topical Pregnancy and Breastfeeding Warnings

Brand names: Borofax, Hylafem

Boric acid topical Pregnancy Warnings

Use is contraindicated.

US FDA pregnancy category: Not assigned

Comments:
-There is no data on use in pregnant women to know this drugs risks, including the risk of fetal harm or reproductive effects.

Animal studies are not available. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Boric acid topical Breastfeeding Warnings

Use is contraindicated.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments:
-There is no information regarding this drug on the presence in human milk, the effects on a breastfed infant, or effects on milk production.

See references

References for pregnancy information

  1. (2001) "Product Information. Boric Acid (boric acid topical)." Fougera
  2. (2019) "Product Information. Hylafem (boric acid topical)." US Pharmaceutical Corporation

References for breastfeeding information

  1. (2001) "Product Information. Boric Acid (boric acid topical)." Fougera
  2. (2019) "Product Information. Hylafem (boric acid topical)." US Pharmaceutical Corporation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer